BioSpace News Archive

PayPal Holdings, Inc. has been carefully assessing the effect of COVID-19 as conditions continue to evolve.

China Xiangtai Food Co. Ltd., an emerging growth company primarily engaged in pork processing in China, announced that the Company has launched online ordering service to communities in Chongqing, China where residents have limited outdoor access to food purchase due to the implemented epidemic control regulations following the spread of COVID-19.

Advaxis, Inc. (Nasdaq: ADXS), a clinical-stage biotechnology company focused on the development and commercialization of immunotherapy products today announced updated results from the combination arms of the Company’s ongoing Phase 1/2 study.

RedHawk Nearing Completion of Steps Necessary to Seek Medicare and Medicaid Accreditation

AnPac Bio-Medical Science Co., Ltd. today announced that it has filed a provisional patent application on the use of AnPac Bio’s novel detection technology, methods and apparatus for coronavirus detection with the US Patent Trademark and Office

Copyright Clearance Center, Inc. (CCC), a leader in advancing copyright, accelerating knowledge, and powering innovation, announces the publishing unit of the Commonwealth Scientific and Industrial Research Organisation

Oxford Immunotec Global PLC (Nasdaq: OXFD), a global, high-growth diagnostics company, today announced that Dr. Peter Wrighton-Smith, Chief Executive Officer, will present at the Cowen and Company 40th Annual Health Care Conference on Tuesday, March 3, 2020, at 12:00 p.m. EST at the Boston Marriott Copley Place in Boston.

Avion Pharmaceuticals, LLC, a specialty pharmaceutical company, announced its gout prophylaxis product, GLOPERBA® (colchicine), is now commercially available in pharmacies across the United States.

SQI Diagnostics Inc. (“SQI” or the “Company”) (TSX-V: SQD; OTCQB: SQIDF), today reported its financial and operational results for the three months ended December 31, 2019.

A well-known market intelligence company, Infiniti Research, has announced the completion of its latest article on understanding the value of pharma R&D in the new era.